Show
Sort by
-
- Conference Paper
- C3
- open access
TARP as immunotherapeutic target in AML expressed in the LSC compartment
-
Retrospective study of infant leukaemia in the University Hospitals of Leuven and Ghent
-
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials
-
Identification of candidate oncogenes and chromosomal breakpoint sequencing by targeted locus amplification in T-cell acute lymphoblastic leukemia
-
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951
-
Minimal residual disease quantification by PCR in childhood acute lymphoblastic leukaemia
-
Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia
-
Presentation and outcome of children with down syndrome and acute lymphoblastic leukemia in the eortc children's leukemia group protocol 58951
-
Is the risk of developing AML or MDS increased in X-linked neutropenia
-
Which technique(s) to use when studying minimal residual disease at day 35 in childhood acute lymphoblastic leukemia: a multicenter approach.